Donor Peripheral Stem Cell Transplant and Donor Natural Killer Cell Transplant After Total-Body Irradiation, Thiotepa, Fludarabine, and Muromonab-CD3 in Treating Patients With Leukemia or Other Blood Diseases

Clinical trial NCT00450983 · TERMINATED

Trial details

NCT number: NCT00450983
Sponsor: Fred Hutchinson Cancer Center
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Graft Versus Host Disease Leukemia Myelodysplastic Syndromes

Start date: 2006-12-01
Primary completion: 2010-07-01
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.